New coiling technique aims to stop Re-Bleeding in severe brain aneurysms

NCT ID NCT07250958

Recruiting now Disease control Sponsor: University of Louisville Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at a new way to treat severe brain bleeds caused by aneurysms. Instead of coiling the whole aneurysm, doctors will only coil the dome (the bulging part). The goal is to see if this lowers the risk of re-bleeding and improves recovery. The study will enroll 30 adults with severe bleeds and follow their outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: dome-only aneurysm coiling procedure
What this could lead to: If successful, this could offer a safer way to treat severe brain aneurysms by reducing the chance of re-bleeding.
What could go wrong: This is a small, early observational study with only 30 participants, so results may not apply to all patients. The procedure carries risks like any brain intervention.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEURYSMAL SUBARACHNOID HEMORRHAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acquired aneurysmal subarachnoid hemorrhage subarachnoid hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANEURYSMAL SUBARACHNOID HEMORRHAGE

Contacts and locations

Locations

University of Louisville Hospital
RECRUITING

Louisville, Kentucky, 40202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.